{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T15:26:06Z","timestamp":1773674766827,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T00:00:00Z","timestamp":1479168000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10096-016-2809-3","type":"journal-article","created":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T06:52:06Z","timestamp":1479192726000},"page":"361-371","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment"],"prefix":"10.1007","volume":"36","author":[{"given":"A.","family":"Kossyvakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.-F. A.","family":"Mentis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Tryfinopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Pogka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kalliaropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Antalis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Lytras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tsiodras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Karakitsos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. F.","family":"Mentis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,15]]},"reference":[{"key":"2809_CR1","doi-asserted-by":"publisher","first-page":"CD008965","DOI":"10.1002\/14651858.CD008965.pub4","volume":"4","author":"T Jefferson","year":"2014","unstructured":"Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ, Spencer EA, Onakpoya I, Mahtani KR, Nunan D, Howick J, Heneghan CJ (2014) Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 4:CD008965. doi: 10.1002\/14651858.CD008965.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"9979","key":"2809_CR2","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1016\/S0140-6736(14)62449-1","volume":"385","author":"J Dobson","year":"2015","unstructured":"Dobson J, Whitley RJ, Pocock S, Monto AS (2015) Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials. Lancet 385(9979):1729\u20131737. doi: 10.1016\/S0140-6736(14)62449-1","journal-title":"Lancet"},{"issue":"6428","key":"2809_CR3","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/363418a0","volume":"363","author":"M Itzstein von","year":"1993","unstructured":"von Itzstein M, Wu WY, Kok GB, Pegg MS, Dyason JC, Jin B, Van Phan T, Smythe ML, White HF, Oliver SW et al (1993) Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363(6428):418\u2013423. doi: 10.1038\/363418a0","journal-title":"Nature"},{"issue":"4","key":"2809_CR4","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1021\/ja963036t","volume":"119","author":"CU Kim","year":"1997","unstructured":"Kim CU, Lew W, Williams MA, Liu H, Zhang L, Swaminathan S, Bischofberger N, Chen MS, Mendel DB, Tai CY, Laver WG, Stevens RC (1997) Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J Am Chem Soc 119(4):681\u2013690","journal-title":"J Am Chem Soc"},{"issue":"19","key":"2809_CR5","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1021\/jm0002679","volume":"43","author":"YS Babu","year":"2000","unstructured":"Babu YS, Chand P, Bantia S, Kotian P, Dehghani A, El-Kattan Y, Lin TH, Hutchison TL, Elliott AJ, Parker CD, Ananth SL, Horn LL, Laver GW, Montgomery JA (2000) BCX-1812 (RWJ-270201): discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design. J Med Chem 43(19):3482\u20133486","journal-title":"J Med Chem"},{"issue":"3","key":"2809_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3109\/00498250903447691","volume":"40","author":"K Koyama","year":"2010","unstructured":"Koyama K, Takahashi M, Nakai N, Takakusa H, Murai T, Hoshi M, Yamamura N, Kobayashi N, Okazaki O (2010) Pharmacokinetics and disposition of CS-8958, a long-acting prodrug of the novel neuraminidase inhibitor laninamivir in rats. Xenobiotica 40(3):207\u2013216. doi: 10.3109\/00498250903447691","journal-title":"Xenobiotica"},{"issue":"Suppl 1","key":"2809_CR7","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/irv.12047","volume":"7","author":"JL McKimm-Breschkin","year":"2013","unstructured":"McKimm-Breschkin JL (2013) Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance. Influenza Other Respir Viruses 7(Suppl 1):25\u201336. doi: 10.1111\/irv.12047","journal-title":"Influenza Other Respir Viruses"},{"issue":"4","key":"2809_CR8","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3201\/eid1504.181280","volume":"15","author":"A Meijer","year":"2009","unstructured":"Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, Opp M, Paget J, van de Kassteele J, Hay A, Zambon M (2009) Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season. Emerg Infect Dis 15(4):552\u2013560. doi: 10.3201\/eid1504.181280","journal-title":"Emerg Infect Dis"},{"key":"2809_CR9","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.antiviral.2015.02.003","volume":"117","author":"E Takashita","year":"2015","unstructured":"Takashita E, Meijer A, Lackenby A, Gubareva L, Rebelo-de-Andrade H, Besselaar T, Fry A, Gregory V, Leang SK, Huang W, Lo J, Pereyaslov D, Siqueira MM, Wang D, Mak GC, Zhang W, Daniels RS, Hurt AC, Tashiro M (2015) Global update on the susceptibility of human influenza viruses to neuraminidase inhibitors, 2013-2014. Antiviral Res 117:27\u201338. doi: 10.1016\/j.antiviral.2015.02.003","journal-title":"Antiviral Res"},{"issue":"7","key":"2809_CR10","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3201\/eid1607.091691","volume":"16","author":"AR Tramontana","year":"2010","unstructured":"Tramontana AR, George B, Hurt AC, Doyle JS, Langan K, Reid AB, Harper JM, Thursky K, Worth LJ, Dwyer DE, Morrissey CO, Johnson PD, Buising KL, Harrison SJ, Seymour JF, Ferguson PE, Wang B, Denholm JT, Cheng AC, Slavin M (2010) Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. Emerg Infect Dis 16(7):1068\u20131075. doi: 10.3201\/eid1607.091691","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"2809_CR11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/INF.0b013e3181ff863b","volume":"30","author":"S Carr","year":"2011","unstructured":"Carr S, Ilyushina NA, Franks J, Adderson EE, Caniza M, Govorkova EA, Webster RG (2011) Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer. Pediatr Infect Dis J 30(4):284\u2013288. doi: 10.1097\/INF.0b013e3181ff863b","journal-title":"Pediatr Infect Dis J"},{"issue":"7","key":"2809_CR12","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1128\/AAC.01339-05","volume":"50","author":"AS Monto","year":"2006","unstructured":"Monto AS, McKimm-Breschkin JL, Macken C, Hampson AW, Hay A, Klimov A, Tashiro M, Webster RG, Aymard M, Hayden FG, Zambon M (2006) Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 50(7):2395\u20132402. doi: 10.1128\/AAC.01339-05","journal-title":"Antimicrob Agents Chemother"},{"issue":"5983","key":"2809_CR13","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1126\/science.1187816","volume":"328","author":"JD Bloom","year":"2010","unstructured":"Bloom JD, Gong LI, Baltimore D (2010) Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 328(5983):1272\u20131275. doi: 10.1126\/science.1187816","journal-title":"Science"},{"issue":"12","key":"2809_CR14","doi-asserted-by":"publisher","first-page":"e1002431","DOI":"10.1371\/journal.ppat.1002431","volume":"7","author":"Y Abed","year":"2011","unstructured":"Abed Y, Pizzorno A, Bouhy X, Boivin G (2011) Role of permissive neuraminidase mutations in influenza A\/Brisbane\/59\/2007-like (H1N1) viruses. PLoS Pathog 7(12):e1002431. doi: 10.1371\/journal.ppat.1002431","journal-title":"PLoS Pathog"},{"issue":"7","key":"2809_CR15","doi-asserted-by":"publisher","first-page":"e22201","DOI":"10.1371\/journal.pone.0022201","volume":"6","author":"JD Bloom","year":"2011","unstructured":"Bloom JD, Nayak JS, Baltimore D (2011) A computational-experimental approach identifies mutations that enhance surface expression of an oseltamivir-resistant influenza neuraminidase. PLoS One 6(7):e22201. doi: 10.1371\/journal.pone.0022201","journal-title":"PLoS One"},{"issue":"2","key":"2809_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1093\/infdis\/jis337","volume":"206","author":"AC Hurt","year":"2012","unstructured":"Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Leang SK, Lee RT, Iannello P, Gehrig N, Shaw R, Wark P, Caldwell N, Givney RC, Xue L, Maurer-Stroh S, Dwyer DE, Wang B, Smith DW, Levy A, Booy R, Dixit R, Merritt T, Kelso A, Dalton C, Durrheim D, Barr IG (2012) Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. J Infect Dis 206(2):148\u2013157. doi: 10.1093\/infdis\/jis337","journal-title":"J Infect Dis"},{"issue":"1","key":"2809_CR17","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3201\/eid2101.141006","volume":"21","author":"M Okomo-Adhiambo","year":"2015","unstructured":"Okomo-Adhiambo M, Fry AM, Su S, Nguyen HT, Elal AA, Negron E, Hand J, Garten RJ, Barnes J, Xiyan X, Villanueva JM, Gubareva LV (2015) Oseltamivir-resistant influenza A(H1N1)pdm09 viruses, United States, 2013-14. Emerg Infect Dis 21(1):136\u2013141. doi: 10.3201\/eid2101.141006","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"2809_CR18","doi-asserted-by":"publisher","first-page":"e1005404","DOI":"10.1371\/journal.pgen.1005404","volume":"11","author":"AD Neverov","year":"2015","unstructured":"Neverov AD, Kryazhimskiy S, Plotkin JB, Bazykin GA (2015) Coordinated evolution of influenza A surface proteins. PLoS Genet 11(8):e1005404. doi: 10.1371\/journal.pgen.1005404","journal-title":"PLoS Genet"},{"issue":"10","key":"2809_CR19","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1093\/jac\/dkt205","volume":"68","author":"JL McKimm-Breschkin","year":"2013","unstructured":"McKimm-Breschkin JL, Williams J, Barrett S, Jachno K, McDonald M, Mohr PG, Saito T, Tashiro M (2013) Reduced susceptibility to all neuraminidase inhibitors of influenza H1N1 viruses with haemagglutinin mutations and mutations in non-conserved residues of the neuraminidase. J Antimicrob Chemother 68(10):2210\u20132221. doi: 10.1093\/jac\/dkt205","journal-title":"J Antimicrob Chemother"},{"key":"2809_CR20","unstructured":"WHO (2015) Antimicrobial resistance. http:\/\/www.who.int\/mediacentre\/factsheets\/fs194\/en\/ . Accessed 18 Jul 2016"},{"key":"2809_CR21","doi-asserted-by":"crossref","unstructured":"Athanasiou M, Baka A, Andreopoulou A, Spala G, Karageorgou K, Kostopoulos L, Patrinos S, Sideroglou T, Triantafyllou E, Mentis A, Malisiovas N, Lytras T, Tsiodras S, Panagiotopoulos T, Bonovas S (2011) Influenza surveillance during the post-pandemic influenza 2010\/11 season in Greece, 04 October 2010 to 22 May 2011. Euro Surveill 16(44)","DOI":"10.2807\/ese.16.44.20004-en"},{"key":"2809_CR22","unstructured":"ECDC (2014) Consumption of Neuraminidase Inhibitors (ATC group J05AH) in the community and hospital sector in Europe. http:\/\/ecdc.europa.eu\/en\/healthtopics\/antimicrobial_resistance\/esac-net-database\/Pages\/Antimicrobial-consumption-rates-by-countryaspx%23sthashPWTRV36edpuf . Accessed 18 Jul 2016"},{"key":"2809_CR23","unstructured":"WHO (2014) WHO surveillance case definitions for ILI and SARI. http:\/\/www.who.int\/influenza\/surveillance_monitoring\/ili_sari_surveillance_case_definition\/en\/ . Accessed 22 Jul 2016"},{"key":"2809_CR24","unstructured":"WHO (2010) Selection of clinical specimens for virus isolation and of viruses for shipment from National Influenza Centres to WHO Collaborating Centres. http:\/\/www.who.int\/influenza\/gisrs_laboratory\/national_influenza_centres\/20101206_specimens_selected_for_virus_isolation_and_shipment.pdf . Accessed 22 Jul 2016"},{"key":"2809_CR25","unstructured":"WHO (2011) Manual for the laboratory diagnosis and virological surveillance of influenza. http:\/\/apps.who.int\/iris\/bitstream\/10665\/44518\/1\/9789241548090_eng.pdf . Accessed 19 Jul 2016"},{"issue":"6","key":"2809_CR26","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1177\/135965350801300602","volume":"13","author":"A Lackenby","year":"2008","unstructured":"Lackenby A, Democratis J, Siqueira MM, Zambon MC (2008) Rapid quantitation of neuraminidase inhibitor drug resistance in influenza virus quasispecies. Antivir Ther 13(6):809\u2013820","journal-title":"Antivir Ther"},{"issue":"39","key":"2809_CR27","first-page":"369","volume":"87","author":"WHO","year":"2012","unstructured":"WHO (2012) Meetings of the WHO working group on surveillance of influenza antiviral susceptibility\u2013Geneva, November 2011 and June 2012. Wkly Epidemiol Rec 87(39):369\u2013374","journal-title":"Wkly Epidemiol Rec"},{"key":"2809_CR28","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-3324-9","volume-title":"Density estimation for statistics and data analysis","author":"BW Silverman","year":"1986","unstructured":"Silverman BW (1986) Density estimation for statistics and data analysis. CRC Press, London"},{"key":"2809_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.antiviral.2015.12.002","volume":"126","author":"T Lytras","year":"2016","unstructured":"Lytras T, Kossyvakis A, Mentis A (2016) NAIplot: an opensource web tool to visualize neuraminidase inhibitor (NAI) phenotypic susceptibility results using kernel density plots. Antiviral Res 126:18\u201320. doi: 10.1016\/j.antiviral.2015.12.002","journal-title":"Antiviral Res"},{"issue":"5","key":"2809_CR30","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1128\/JCM.03236-14","volume":"53","author":"A Kossyvakis","year":"2015","unstructured":"Kossyvakis A, Pogka V, Melidou A, Moutousi A, Gioula G, Kalliaropoulos A, Exindari M, Emmanouil M, Horefti E, Spala G, Meijer A, Malisiovas N, Mentis AF (2015) Challenges in antigenic characterization of circulating influenza A(H3N2) viruses during the 2011-2012 influenza season: an ongoing problem? J Clin Microbiol 53(5):1493\u20131499. doi: 10.1128\/JCM.03236-14","journal-title":"J Clin Microbiol"},{"issue":"42","key":"2809_CR31","doi-asserted-by":"publisher","first-page":"5740","DOI":"10.1016\/j.vaccine.2009.07.040","volume":"27","author":"AS Groot De","year":"2009","unstructured":"De Groot AS, Ardito M, McClaine EM, Moise L, Martin WD (2009) Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine. Vaccine 27(42):5740\u20135747. doi: 10.1016\/j.vaccine.2009.07.040","journal-title":"Vaccine"},{"key":"2809_CR32","doi-asserted-by":"publisher","unstructured":"Maurer-Stroh S, Ma J, Lee RTC, Sirota FL, Eisenhaber F (2009) Mapping the sequence mutations of the 2009 H1N1 influenza A virus neuraminidase relative to drug and antibody binding sites. Biol Direct 4 (18). doi: 10.1186\/1745-6150-4-18","DOI":"10.1186\/1745-6150-4-18"},{"issue":"12","key":"2809_CR33","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1093\/molbev\/mst197","volume":"30","author":"K Tamura","year":"2013","unstructured":"Tamura K, Stecher G, Peterson D, Filipski A, Kumar S (2013) MEGA6: molecular evolutionary genetics analysis version 6.0. Mol Biol Evol 30(12):2725\u20132729. doi: 10.1093\/molbev\/mst197","journal-title":"Mol Biol Evol"},{"key":"2809_CR34","unstructured":"WHO (2015) Report prepared for the WHO annual consultation on the composition of influenza vaccine for the Northern Hemisphere 2015\/16. https:\/\/www.crick.ac.uk\/media\/221813\/nimr-report-feb2015-web.pdf . Accessed 20 Jul 2016"},{"key":"2809_CR35","unstructured":"Team RC (2016) R: a language and environment for statistical computing. https:\/\/cran.r-project.org\/doc\/manuals\/r-release\/fullrefman.pdf . Accessed 20 Jul 2016"},{"key":"2809_CR36","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.coviro.2014.04.009","volume":"8","author":"AC Hurt","year":"2014","unstructured":"Hurt AC (2014) The epidemiology and spread of drug resistant human influenza viruses. Curr Opin Virol 8:22\u201329. doi: 10.1016\/j.coviro.2014.04.009","journal-title":"Curr Opin Virol"},{"issue":"2","key":"2809_CR37","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jcv.2010.10.007","volume":"50","author":"M Alonso","year":"2011","unstructured":"Alonso M, Rodriguez-Sanchez B, Giannella M, Catalan P, Gayoso J, Lopez Bernaldo de Quiros JC, Bouza E, Garcia de Viedma D (2011) Resistance and virulence mutations in patients with persistent infection by pandemic 2009 A\/H1N1 influenza. J Clin Virol 50(2):114\u2013118. doi: 10.1016\/j.jcv.2010.10.007","journal-title":"J Clin Virol"},{"issue":"36","key":"2809_CR38","doi-asserted-by":"crossref","first-page":"20266","DOI":"10.2807\/ese.17.36.20266-en","volume":"17","author":"A Meijer","year":"2012","unstructured":"Meijer A, Jonges M, van Beek P, Swaan CM, Osterhaus AD, Daniels RS, Hurt AC, Koopmans MP (2012) Oseltamivir-resistant influenza A(H1N1)pdm09 virus in Dutch travellers returning from Spain, August 2012. Euro Surveill 17(36):20266","journal-title":"Euro Surveill"},{"key":"2809_CR39","doi-asserted-by":"crossref","unstructured":"Lackenby A, Moran Gilad J, Pebody R, Miah S, Calatayud L, Bolotin S, Vipond I, Muir P, Guiver M, McMenamin J, Reynolds A, Moore C, Gunson R, Thompson C, Galiano M, Bermingham A, Ellis J, Zambon M (2011) Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010\/11. Euro Surveill 16(5)","DOI":"10.2807\/ese.16.05.19784-en"},{"issue":"2","key":"2809_CR40","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3201\/eid1802.111466","volume":"18","author":"AD Storms","year":"2012","unstructured":"Storms AD, Gubareva LV, Su S, Wheeling JT, Okomo-Adhiambo M, Pan CY, Reisdorf E, St George K, Myers R, Wotton JT, Robinson S, Leader B, Thompson M, Shannon M, Klimov A, Fry AM (2012) Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010\u201311. Emerg Infect Dis 18(2):308\u2013311. doi: 10.3201\/eid1802.111466","journal-title":"Emerg Infect Dis"},{"issue":"26","key":"2809_CR41","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1056\/NEJMc1111078","volume":"365","author":"AC Hurt","year":"2011","unstructured":"Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Gehrig N, Kelso A (2011) Community transmission of oseltamivir-resistant A(H1N1)pdm09 influenza. N Engl J Med 365(26):2541\u20132542. doi: 10.1056\/NEJMc1111078","journal-title":"N Engl J Med"},{"key":"2809_CR42","doi-asserted-by":"publisher","unstructured":"Valkenburg SA, Qui\u00f1ones-Parra S, Gras S, Komadina N, McVernon J, Wang Z, Halim H, Iannello P, Cole C, Laurie K, Kelso A, Rossjohn J, Doherty PC, Turner SJ, Kedzierska K (2013) Acute emergence and reversion of influenza A virus quasispecies within CD8+ T cell antigenic peptides. Nature Commun 4. doi: 10.1038\/ncomms3663","DOI":"10.1038\/ncomms3663"},{"issue":"5","key":"2809_CR43","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/irv.12113","volume":"7","author":"M Okomo-Adhiambo","year":"2013","unstructured":"Okomo-Adhiambo M, Sleeman K, Lysen C, Nguyen HT, Xu X, Li Y, Klimov AI, Gubareva LV (2013) Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season. Influenza Other Respir Viruses 7(5):645\u2013658. doi: 10.1111\/irv.12113","journal-title":"Influenza Other Respir Viruses"},{"issue":"6","key":"2809_CR44","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/irv.12108","volume":"7","author":"AC Hurt","year":"2013","unstructured":"Hurt AC, Leang SK, Tiedemann K, Butler J, Mechinaud F, Kelso A, Downie P, Barr IG (2013) Progressive emergence of an oseltamivir-resistant A(H3N2) virus over two courses of oseltamivir treatment in an immunocompromised paediatric patient. Influenza Other Respir Viruses 7(6):904\u2013908. doi: 10.1111\/irv.12108","journal-title":"Influenza Other Respir Viruses"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2809-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-016-2809-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2809-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T14:47:31Z","timestamp":1657723651000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-016-2809-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,15]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["2809"],"URL":"https:\/\/doi.org\/10.1007\/s10096-016-2809-3","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,15]]}}}